# Victor J. Dzau (1945)

> Medico-scienziato sino-americano, pioniere degli ACE-inibitori, architetto della governance sanitaria globale tra accademia, fondazioni e preparedness pandemica

## Dati Essenziali

| Aspetto | Dettaglio |
|---------|-----------|
| **Nascita** | 23 ottobre 1945, Shanghai, Cina |
| **Famiglia** | Nato in Cina, rifugiato a Hong Kong nel 1950 |
| **Nazionalita'** | USA-CHN |
| **Residenza** | Washington DC, USA |

---

## Formazione

| Periodo | Istituzione | Dettaglio |
|---------|-------------|-----------|
| **-1972** | [McGill University](../university/mcgill.md) | BSc Biology, MD |
| **-** | St. Joseph's College | Hong Kong, scuola superiore |

**Background:**
- Emigrato dalla Cina a Hong Kong a 5 anni (1950), durante la persecuzione comunista
- Primo immigrato e prima persona di colore a guidare una delle tre National Academies USA

---

## Carriera e Ruoli

### Timeline Professionale

| Periodo | Ruolo | Organizzazione |
|---------|-------|----------------|
| **1990-1996** | Chairman Dept. Medicine | [Stanford University](../university/stanford.md) |
| **1996-2004** | Chairman Dept. Medicine | [Harvard Medical School](../university/harvard.md) / Brigham and Women's Hospital |
| **2004-2014** | Chancellor for Health Affairs, CEO | [Duke University Health System](../think-tank/duke-university.md) |
| **2005-** | Founder | [Duke-NUS Medical School](../university/duke-nus.md) |
| **2014-** | President | [National Academy of Medicine](../agency/national-academy-of-medicine.md) |
| **2018-** | Board Member | [GPMB](../agency/gpmb.md) |
| **-** | Board Member | [CEPI](../agency/cepi.md) (interim) |
| **-** | Board Member | [IHME](../think-tank/ihme.md) |
| **-** | Board Member | [Imperial College Health Partners](../think-tank/imperial-college-health-partners.md) |

### Ruoli Chiave COVID-19

| Organizzazione | Ruolo |
|----------------|-------|
| **GPMB** | Inaugural board member |
| **ACT-Accelerator** | Principal |
| **CEPI** | Interim board |
| **G20 Scientific Expert Panel** | Co-Chair |
| **G20 High Level Independent Panel** | Advisor (Pandemic Financing) |

---

## Rete di Connessioni

### Mappa delle Appartenenze

```
                        VICTOR DZAU
                             |
        +--------------------+--------------------+
        |                    |                    |
    ACADEMIA             GOVERNANCE           PANDEMIC
        |                    |               PREPAREDNESS
   +----+----+          +----+----+          +----+----+
   |    |    |          |         |          |    |    |
Stanford Harvard  Duke  NAM    Duke-NUS    GPMB CEPI  ACT
(90-96) (96-04) (04-14)(2014-)  (2005-)   (2018) (int) Accel.
                                             |
                                          +--+--+
                                          |     |
                                        IHME   WEF
```

### Forum Internazionali

| Forum | Partecipazione |
|-------|----------------|
| **WEF Davos** | Speaker regolare, Health Governors Policy Forum, Vaccine Manufacturing Collaborative |
| **G20** | Co-Chair Scientific Expert Panel, Advisor Pandemic Financing |

### Advisory Boards Internazionali

| Organizzazione | Ruolo |
|----------------|-------|
| Health & Biomedical Sciences Council Singapore | Member |
| Qatar Precision Health Institute | Chair Scientific Advisory |
| Qatar Genome Programme | Chair Scientific Advisory |
| Imperial College Health Partners | Board |
| Research!America | Board |

### Network Professionale

| Nome | Connessione |
|------|-------------|
| [Chris Elias](../persons/chris-elias.md) | Fellow GPMB board member |
| [Henrietta Fore](../persons/henrietta-fore.md) | Fellow GPMB board member |
| [Gro Harlem Brundtland](../persons/gro-harlem-brundtland.md) | GPMB founding Co-Chair |

---

## Potere Esercitato

### Ricerca Scientifica

| Aspetto | Dettaglio |
|---------|-----------|
| **ACE Inhibitors** | Ricerca fondamentale per lo sviluppo degli ACE-inibitori, usati globalmente per ipertensione e insufficienza cardiaca |
| **Gene Therapy** | Primo a introdurre molecole DNA decoy per bloccare trascrizione come gene therapy in umani |
| **Cardiac Regeneration** | Paracrine Hypothesis of stem cell action, direct cardiac reprogramming |
| **CRISPR** | Lancio Human Genome Editing Initiative alla NAM |

### Institution Building

| Aspetto | Dettaglio |
|---------|-----------|
| **Duke Global Health Institute** | Fondatore |
| **Duke-NUS Medical School** | Fondatore (Singapore, 2005) |
| **Global Health Equity Division** | Fondatore (Harvard) |
| **Association of Academic Health Centers** | Past Board Chair |

### Governance Sanitaria Globale

| Aspetto | Dettaglio |
|---------|-----------|
| **NAM** | Presidente dal 2014 - trasformazione in National Academy of Medicine |
| **GPMB** | Inaugural member - monitoraggio preparedness pandemica |
| **ACT-Accelerator** | Principal - accesso globale vaccini COVID-19 |
| **CEPI** | Interim board - sviluppo vaccini per epidemie |

---

## Primati

| Anno | Primato |
|------|---------|
| **2014** | Primo immigrato a guidare una delle tre National Academies USA |
| **2014** | Prima persona di colore a guidare una delle tre National Academies |
| **2020** | Primo presidente NAM eletto (non nominato) dai membri |

---

## Riconoscimenti

| Anno | Premio |
|------|--------|
| **2011** | Henry G. Friesen International Prize in Health Research |
| **2016** | Ellis Island Medal of Honor |
| **2017** | Research!America Lifetime Achievement Award |
| **2025** | Honorary Doctor of Science, University of Michigan |

### Membership Accademie

- National Academy of Medicine (USA)
- American Academy of Arts and Sciences
- European Academy of Sciences and Arts
- Academia Sinica (Taiwan)
- Chinese Academy of Engineering
- Japan Academy

---

## Connessioni PowerLink

### Organizzazioni

| Entita' | Connessione |
|---------|-------------|
| [National Academy of Medicine](../agency/national-academy-of-medicine.md) | President 2014- |
| [GPMB](../agency/gpmb.md) | Board 2018- |
| [Duke University](../think-tank/duke-university.md) | Chancellor Emeritus, CEO DUHS 2004-2014 |
| [Duke-NUS Medical School](../university/duke-nus.md) | Founder 2005 |
| [Harvard](../university/harvard.md) | Chairman Medicine 1996-2004 |
| [Stanford](../university/stanford.md) | Chairman Medicine 1990-1996 |
| [McGill University](../university/mcgill.md) | Alumni (BSc, MD 1972) |
| [CEPI](../agency/cepi.md) | Interim board |
| [IHME](../think-tank/ihme.md) | Board |
| [Imperial College Health Partners](../think-tank/imperial-college-health-partners.md) | Board |
| [WEF](../forum/wef.md) | Speaker Davos |

### Eventi

| Evento | Ruolo |
|--------|-------|
| [Pandemia COVID-19](../events/2020-covid19.md) | Principal ACT-Accelerator, G20 advisor |

---

## Timeline

| Anno | Evento |
|------|--------|
| **1945** | Nasce a Shanghai |
| **1950** | Emigra a Hong Kong come rifugiato |
| **1972** | MD, McGill University |
| **1990** | Chairman Dept. Medicine, Stanford |
| **1996** | Chairman Dept. Medicine, Harvard/Brigham |
| **2004** | Chancellor Duke University Health System |
| **2005** | Fonda Duke-NUS Medical School (Singapore) |
| **2014** | Presidente National Academy of Medicine |
| **2018** | Board GPMB |
| **2020** | Rieletto Presidente NAM (primo eletto) |
| **2020** | Principal ACT-Accelerator per COVID-19 |
| **2025** | Laurea honoris causa University of Michigan |

---

## Osservazioni

**Profilo tipico della governance sanitaria globale:**
- Carriera accademica d'elite (Stanford → Harvard → Duke)
- Transizione da ricerca a institution-building a policy
- Network che connette academia USA, istituzioni globali (WHO/WB ecosystem), fondazioni
- Ruolo chiave in preparedness pandemica pre e durante COVID-19

**Pattern "Immigrant Success Story":**
Il background di rifugiato cinese e la narrativa "first immigrant/first person of color" rafforza la legittimita' delle istituzioni che guida, presentandole come meritocratiche.

**Ponte USA-Asia:**
Duke-NUS Singapore e advisory roles in Qatar/Singapore mostrano il ruolo di connector tra sistema sanitario USA e Asia.

---

## Fonti

### Ufficiali
- [NAM - Victor J. Dzau](https://nam.edu/team/victor-j-dzau/)
- [National Academies - Leadership](https://www.nationalacademies.org/leadership/3)
- [GPMB - Board Member](https://www.gpmb.org/board/item/prof.-victor-j-dzau)

### Istituzioni
- [Duke University - Victor Dzau](https://today.duke.edu/2004/04/dzau_0404.html)
- [Research!America - Board](https://www.researchamerica.org/board_and_leadership/victor-j-dzau-md/)
- [IHME - Victor Dzau](https://www.healthdata.org/about/people/victor-dzau)

### Wikipedia
- [Wikipedia - Victor Dzau](https://en.wikipedia.org/wiki/Victor_Dzau)

### News/Premi
- [McGill - Friesen Prize 2011](https://publications.mcgill.ca/medenews/2011/09/14/dr-victor-j-dzau-wins-prestigious-international-friesen-prize-in-health-research/)
- [HKU - Honorary Degree](https://www4.hku.hk/hongrads/graduates/dr-victor-joseph-dzau)

---

*Ultimo aggiornamento: Febbraio 2026*
